These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 1646100

  • 21. Characterisation of CTL and IFN-gamma synthesis in ponies following vaccination with a NYVAC-based construct coding for EHV-1 immediate early gene, followed by challenge infection.
    Paillot R, Ellis SA, Daly JM, Audonnet JC, Minke JM, Davis-Poynter N, Hannant D, Kydd JH.
    Vaccine; 2006 Mar 06; 24(10):1490-500. PubMed ID: 16269205
    [Abstract] [Full Text] [Related]

  • 22. Attempts to immunoprotect adult horses, specifically pregnant mares, with commercial vaccines against clinical disease induced by equine herpesvirus-1.
    Bürki F, Nowotny N, Oulehla J, Schmehlik O, Möstl K, Pallan C, Rossmanith E.
    Zentralbl Veterinarmed B; 1991 Aug 06; 38(6):432-40. PubMed ID: 1659067
    [Abstract] [Full Text] [Related]

  • 23. ADCC and complement-dependent lysis as immune mechanisms against EHV-1 infection in the horse.
    Stokes A, Wardley RC.
    Res Vet Sci; 1988 May 06; 44(3):295-302. PubMed ID: 2841731
    [Abstract] [Full Text] [Related]

  • 24. Safety and efficacy of a thymidine kinase negative equine herpesvirus-1 vaccine in young horses.
    Cornick J, Martens J, Martens R, Crandell R, McConnell S, Kit S.
    Can J Vet Res; 1990 Apr 06; 54(2):260-6. PubMed ID: 2162730
    [Abstract] [Full Text] [Related]

  • 25. Clinical and virological evaluation of the efficacy of an inactivated EHV1 and EHV4 whole virus vaccine (Duvaxyn EHV1,4). Vaccination/challenge experiments in foals and pregnant mares.
    Heldens JG, Hannant D, Cullinane AA, Prendergast MJ, Mumford JA, Nelly M, Kydd JH, Weststrate MW, van den Hoven R.
    Vaccine; 2001 Jul 20; 19(30):4307-17. PubMed ID: 11457558
    [Abstract] [Full Text] [Related]

  • 26. Control of EHV-1 viremia and nasal shedding by commercial vaccines.
    Goehring LS, Wagner B, Bigbie R, Hussey SB, Rao S, Morley PS, Lunn DP.
    Vaccine; 2010 Jul 19; 28(32):5203-11. PubMed ID: 20538091
    [Abstract] [Full Text] [Related]

  • 27. Live-attenuated recombinant equine herpesvirus type 1 (EHV-1) induces a neutralizing antibody response against West Nile virus (WNV).
    Rosas CT, Tischer BK, Perkins GA, Wagner B, Goodman LB, Osterrieder N.
    Virus Res; 2007 Apr 19; 125(1):69-78. PubMed ID: 17241683
    [Abstract] [Full Text] [Related]

  • 28. Towards a vaccine against equine herpesvirus 1.
    Sabine M, Whalley JM.
    Aust Vet J; 1989 Dec 19; 66(12):403-4. PubMed ID: 2559691
    [No Abstract] [Full Text] [Related]

  • 29. The equine immune response to equine herpesvirus-1: the virus and its vaccines.
    Kydd JH, Townsend HG, Hannant D.
    Vet Immunol Immunopathol; 2006 May 15; 111(1-2):15-30. PubMed ID: 16476492
    [Abstract] [Full Text] [Related]

  • 30. [Equine rhinopneumonitis virus infection in horses. II (author's transl)].
    Dijkstra RG, de Boer GF.
    Tijdschr Diergeneeskd; 1976 May 01; 101(9):494-7. PubMed ID: 178066
    [No Abstract] [Full Text] [Related]

  • 31. [Relevance of infection with equine herpesvirus 1 (EHV-1) in a German thoroughbred stud: vaccination, abortion and diagnosis].
    Schröer U, Lange A, Glatzel P, Ludwig H, Borchers K.
    Berl Munch Tierarztl Wochenschr; 2000 Feb 01; 113(2):53-9. PubMed ID: 10726362
    [Abstract] [Full Text] [Related]

  • 32. One way protection between equid herpesvirus 1 and 4 in vivo.
    Edington N, Bridges CG.
    Res Vet Sci; 1990 Mar 01; 48(2):235-9. PubMed ID: 2159176
    [Abstract] [Full Text] [Related]

  • 33. Derivation and characterisation of a live equid herpes virus-1 (EHV-1) vaccine to protect against abortion and respiratory disease due to EHV-1.
    Patel JR, Bateman H, Williams J, Didlick S.
    Vet Microbiol; 2003 Jan 02; 91(1):23-39. PubMed ID: 12441229
    [Abstract] [Full Text] [Related]

  • 34. Letter: Efficacy of modified live-virus equine rhinopneumonitis vaccine.
    Stear RL, Bass EP, Beckenhauer WH.
    Am J Vet Res; 1976 Mar 02; 37(3):349-51. PubMed ID: 176909
    [No Abstract] [Full Text] [Related]

  • 35. Trials of an inactivated equid herpesvirus 1 vaccine: challenge with a subtype 1 virus.
    Burrows R, Goodridge D, Denyer MS.
    Vet Rec; 1984 Apr 14; 114(15):369-74. PubMed ID: 6328728
    [Abstract] [Full Text] [Related]

  • 36. Antibody and cellular immune responses following DNA vaccination and EHV-1 infection of ponies.
    Soboll G, Hussey SB, Whalley JM, Allen GP, Koen MT, Santucci N, Fraser DG, Macklin MD, Swain WF, Lunn DP.
    Vet Immunol Immunopathol; 2006 May 15; 111(1-2):81-95. PubMed ID: 16549215
    [Abstract] [Full Text] [Related]

  • 37. Cellular and antibody responses to equine herpesviruses 1 and 4 following vaccination of horses with modified-live and inactivated viruses.
    Ellis JA, Bogdan JR, Kanara EW, Morley PS, Haines DM.
    J Am Vet Med Assoc; 1995 Mar 15; 206(6):823-32. PubMed ID: 7538990
    [Abstract] [Full Text] [Related]

  • 38. Prevalence of equine herpesvirus-1 and equine herpesvirus-4 infections in equidae species in Turkey as determined by ELISA and multiplex nested PCR.
    Ataseven VS, Dağalp SB, Güzel M, Başaran Z, Tan MT, Geraghty B.
    Res Vet Sci; 2009 Apr 15; 86(2):339-44. PubMed ID: 18649902
    [Abstract] [Full Text] [Related]

  • 39. Genomic and antigenic comparison of an equine herpesvirus 1 (EHV 1) isolate from the 1983 Lippizan abortion storm with EHV 1 reference strains.
    Engels M, Nowotny N, Metzler AE, Wyler R, Bürki F.
    Microbiologica; 1986 Apr 15; 9(2):221-34. PubMed ID: 3012290
    [Abstract] [Full Text] [Related]

  • 40. Serological responses of mares and weanlings following vaccination with an inactivated whole virus equine herpesvirus 1 and equine herpesvirus 4 vaccine.
    Foote CE, Love DN, Gilkerson JR, Whalley JM.
    Vet Microbiol; 2002 Aug 02; 88(1):13-25. PubMed ID: 12119135
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.